Cite
Molecular docking simulation and anticancer assessment on human breast carcinoma cell line using novel bis(1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile) and bis(1,4-dihydropyrazolo[4′,3′:5,6]pyrano[2,3-b]pyridine-6-carbonitrile) derivatives
MLA
Salama, Soad K., et al. “Molecular Docking Simulation and Anticancer Assessment on Human Breast Carcinoma Cell Line Using Novel Bis(1,4-Dihydropyrano[2,3-c]Pyrazole-5-Carbonitrile) and Bis(1,4-Dihydropyrazolo[4′,3′:5,6]Pyrano[2,3-b]Pyridine-6-Carbonitrile) Derivatives.” Bioorganic Chemistry, vol. 71, Apr. 2017, pp. 19–29. EBSCOhost, https://doi.org/10.1016/j.bioorg.2017.01.009.
APA
Salama, S. K., Mohamed, M. F., Darweesh, A. F., Elwahy, A. H. M., & Abdelhamid, I. A. (2017). Molecular docking simulation and anticancer assessment on human breast carcinoma cell line using novel bis(1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile) and bis(1,4-dihydropyrazolo[4′,3′:5,6]pyrano[2,3-b]pyridine-6-carbonitrile) derivatives. Bioorganic Chemistry, 71, 19–29. https://doi.org/10.1016/j.bioorg.2017.01.009
Chicago
Salama, Soad K., Magda F. Mohamed, Ahmed F. Darweesh, Ahmed H.M. Elwahy, and Ismail A. Abdelhamid. 2017. “Molecular Docking Simulation and Anticancer Assessment on Human Breast Carcinoma Cell Line Using Novel Bis(1,4-Dihydropyrano[2,3-c]Pyrazole-5-Carbonitrile) and Bis(1,4-Dihydropyrazolo[4′,3′:5,6]Pyrano[2,3-b]Pyridine-6-Carbonitrile) Derivatives.” Bioorganic Chemistry 71 (April): 19–29. doi:10.1016/j.bioorg.2017.01.009.